These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 9608556)

  • 1. [Botulinum toxin in spasticity treatment].
    Sławek J
    Neurol Neurochir Pol; 1998; 32 Suppl 1():71-84. PubMed ID: 9608556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP; On AY; Kirazli Y; Ismail F; Boulias C
    Neurosci Lett; 2013 Apr; 541():20-3. PubMed ID: 23458671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin for spasticity in children with cerebral palsy: a comprehensive evaluation.
    Bjornson K; Hays R; Graubert C; Price R; Won F; McLaughlin JF; Cohen M
    Pediatrics; 2007 Jul; 120(1):49-58. PubMed ID: 17606561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of botulinum toxin injection with and without needle electromyographic guidance for the treatment of spasticity in hemiplegic patients: a randomized controlled trial.
    Ploumis A; Varvarousis D; Konitsiotis S; Beris A
    Disabil Rehabil; 2014; 36(4):313-8. PubMed ID: 23672209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Guidelines for the treatment of spasticity in adults using Botulinum toxin].
    Aguilar-Barberá M; Bori-Fortuny I; García-Aymerich V; García-Ruiz Espiga PJ; Garreta-Figuera R; Herrera-Galante A; Lanzas-Melendo G; de Miguel-León I; Miquel-Rodríguez F; Pascual-Pascual SI; Póo P; Vivancos-Matellano F
    Rev Neurol; 2004 May 16-31; 38(10):971-8. PubMed ID: 15175981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What are the long-term consequences of botulinum toxin injections in spastic cerebral palsy?
    Barrett RS
    Dev Med Child Neurol; 2011 Jun; 53(6):485. PubMed ID: 21518344
    [No Abstract]   [Full Text] [Related]  

  • 10. Botulinum toxin treatment of adult spasticity : a benefit-risk assessment.
    Sheean G
    Drug Saf; 2006; 29(1):31-48. PubMed ID: 16454533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A treatment of adult upper and lower limb spasticity.
    Hesse S; Brandi-Hesse B; Bardeleben A; Werner C; Funk M
    Drugs Aging; 2001; 18(4):255-62. PubMed ID: 11341473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A; Micello MF; Panza F; Fortunato F; Pilotto A; Giustini A; Testa A; Fiore P; Ranieri M; Spidalieri R
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum Toxin Type A for the Treatment of Lower Limb Spasticity after Stroke.
    Santamato A; Cinone N; Panza F; Letizia S; Santoro L; Lozupone M; Daniele A; Picelli A; Baricich A; Intiso D; Ranieri M
    Drugs; 2019 Feb; 79(2):143-160. PubMed ID: 30623347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxin type A in children. New indication for limb spasticity.
    Prescrire Int; 2011 Mar; 20(114):68. PubMed ID: 21648226
    [No Abstract]   [Full Text] [Related]  

  • 16. [Botulinum toxin type A in the management of spasticity in adults: recommendations of an interdisciplinary group of experts].
    Sławek J; Bogucki A; Banach M; Członkowska A; Friedman A; Krawczyk M; Kwolek A; Opara J; Ochudło S; Zaborski J
    Neurol Neurochir Pol; 2004; 38(6):443-5. PubMed ID: 15654667
    [No Abstract]   [Full Text] [Related]  

  • 17. Botulinum toxin for the treatment of spasticity in children: attainment of treatment goals.
    Weigl DM; Arbel N; Katz K; Becker T; Bar-On E
    J Pediatr Orthop B; 2007 Jul; 16(4):293-6. PubMed ID: 17527109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin type A for upper limb spasticity after stroke.
    Shaw L; Rodgers H
    Expert Rev Neurother; 2009 Dec; 9(12):1713-25. PubMed ID: 19951131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of botulinum toxin type-B in the treatment of patients who have become unresponsive to botulinum toxin type-A -- initial experiences.
    Barnes MP; Best D; Kidd L; Roberts B; Stark S; Weeks P; Whitaker J
    Eur J Neurol; 2005 Dec; 12(12):947-55. PubMed ID: 16324088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.